Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04722640
Status:
UNKNOWN
Last Update Posted:
2021-01-29
First Post:
2021-01-20
Brief Title:
Exploring the Effects of IL-23 Inhibition by Risankizumab on Psoriasis Autoimmunity
Sponsor:
Istituto Clinico Humanitas
Organization:
Istituto Clinico Humanitas
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Psoriasis |
Keywords: